The traditional approach to the treatment of patients with achalasia is based on stretching or cutting the muscle fibres at the oesophagogastric junction by pneumatic dilatation'6 or surgical myotomy.7 12 More recently, nitro derivatives and calcium antagonists, particularly nifedipine, have been proved to be effective in reducing lower oesophageal pressure and improving oesophageal emptying in patients with achalasia.' '7 The results obtained both with surgical or mechanical procedures, such as myotomy and dilatation, and with drug treatment are well known."'0 No prospective study, however, has been reported comparing drug treatment with nifedipine and pneumatic dilatation.
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The aim of our study was to perform such a prospective trial to determine whether there is a significant difference in the results of both treatments.
Methods
Thirty consecutive patients with clinical, radiological, endoscopic, and manometric evidence of oesophageal achalasia, stage I or II using the classification of Adams et al,2' were randomly assigned to two groups. Patients with sigmoid dilatation of the oesophagus or those who had had treatment for achalasia were excluded. Group A had 16 patients assigned to undergo pneumatic dilatation (seven men, nine women; mean age 49.5 years, range 18-82 years). The mean duration of symptoms was 4-1 years (range 6 months-8 years) and the mean oesophageal diameter 3-8 cm (range 2-6 cm). Group B had 14 patients who were treated with sublingual nifedipine (six men, eight women; mean age 51-3 years, range 17-83 years). The mean duration of symptoms was 3.5 years (range 6 months-7 years) and the mean oesophageal diameter 3.9 cm (range 2.5-6 cm).
CLINICAL STUDY
The patients were examined and details of the severity of dysphagia, regurgitation, retrosternal pain, and weight loss were taken before the study and every three months for a mean follow up of 21.4 
